Discover
HALO
Halozyme Therapeutics, Inc.
77.01
1 x 72.13
1 x 79.90
bid
ask
-
1.26
1.61%
1 @ 04:00 PM
77.35 +0.34 (0.44%)
| Ytd | 14.43% | |
| 1y | 45.52% |
75.71
day range
78.49
52.72
52 week range
82.22
| Open | 78.49 | Prev Close | 78.27 | Low | 75.71 | High | 78.49 | Mkt Cap | 9.13B |
| Vol | 1.59M | Avg Vol | 1.72M | EPS | 2.85 | P/E | 27.02 | Forward P/E | 7.91 |
| Beta | 0.87 | Short Ratio | 7.53 | Inst. Own | 107.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 68.80 | 200-d Avg | 69.09 | 1yr Est | 83.90 |
HALO News
prnewswire.com
Halozyme Appoints David Ramsay as President Drug Delivery
SAN DIEGO, June 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or t
benzinga.com
Halozyme Sees Little Royalty Impact From Medicare Drug Pricing Rule, Says CMS Proposal Should Not Hu
Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today confir